Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells
Journal of Immunology - United States
doi 10.4049/jimmunol.168.9.4462
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2002
Authors
Publisher
The American Association of Immunologists